This artice is free to access.
Many studies and systematic reviews have estimated the healthcare costs of diabetes using a cost-of-illness approach. However, in the studies based on this approach patients’ heterogeneity is rarely taken into account. The aim of this study was to stratify patients with type 2 diabetes into homogeneous cost groups based on demographic and clinical characteristics.
Rucci, P., Avaldi, V. M., Travaglini, C., Ugolini, C., Berti, E., Moro, M. L., & Fantini, M. P. (2020). Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis. PharmacoEconomics - Open, 4(1), 181–190. https://doi.org/10.1007/s41669-019-0166-8